A Cautious Approach to Mitochondrial Replacement
By Françoise Baylis,
Impact Ethics
| 02. 03. 2016
Untitled Document
Today the Institute of Medicine (IOM) released a report, “Mitochondrial Replacement Techniques: Ethical, Social and Policy Considerations.” With this report, written at the request of the Food and Drug Administration, the United States is poised to proceed with research involving mitochondrial replacement.
Mitochondrial replacement research involves the transfer of nuclear DNA from an unfertilized or a fertilized egg (zygote) with dysfunctional mitochondrial DNA into a fertilized or unfertilized egg that has healthy mitochondrial DNA, and has had its nuclear DNA removed. Children born of this technology will have three genetic parents, insofar as they will have genetic material from a male sperm provider and two female egg providers.
This report, authored by the Committee on the Ethical and Social Policy Considerations of Novel Techniques for Prevention of Maternal Transmission of Mitochondrial DNA Diseases, makes a number of important contributions to the ethics and policy debates.
The Committee’s approach to mitochondrial replacement technology is notably more cautious than that adopted in the United Kingdom. The Committee recommends limiting research to the intrauterine transfer of genetically modified male...
Related Articles
By Megan Mineiro and Caroline Kitchener, The New York Times | 10.05.2025
Kathleen Whipple and her husband had dreamed of a big family, but struggled to conceive.
Upon his return from an overseas deployment with the Navy, the couple learned from a fertility doctor that her husband’s sperm count was half of...
By Alondra Nelson, Science | 09.11.2025
In the United States, the summer of 2025 will be remembered as artificial intelligence’s (AI’s) cruel summer—a season when the unheeded risks and dangers of AI became undeniably clear. Recent months have made visible the stakes of the unchecked use...
By Emma McDonald Kennedy
| 09.25.2025
In the leadup to the 2024 election, Donald Trump repeatedly promised to make IVF more accessible. He made the commitment central to his campaign, even referring to himself as the “father of IVF.” In his first month in office, Trump issued an executive order promising to expand IVF access. The order set a 90-day deadline for policy recommendations for “lowering costs and reducing barriers to IVF,” although it didn’t make any substantive reproductive healthcare policy changes.
The response to the...
By Johana Bhuiyan, The Guardian | 09.23.2025
In March 2021, a 25-year-old US citizen was traveling through Chicago’s Midway airport when they were stopped by US border patrol agents. Though charged with no crime, the 25-year-old was subjected to a cheek swab to collect their DNA, which...